Amrita Pati

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Circulating tumor DNA (ctDNA) clearance as an early indicator of sotorasib + panitumumab efficacy and prognosis in <i>KRAS</i> G12C–mutated colorectal cancer (mCRC): Results from phase 3 CodeBreaK 300.

  Journal of Clinical Oncology · 2026-05-27

• Biomarkers of emergent resistance to sotorasib plus panitumumab in <i>KRAS</i> G12C-mutated metastatic colorectal cancer (mCRC) from the randomized, phase 3 CodeBreaK 300 study.

  Journal of Clinical Oncology · 2025-05-28 · 2 citations

• Molecular determinants of sotorasib clinical efficacy in KRASG12C-mutated non-small-cell lung cancer

  Nature Medicine · 2025-05-28 · 32 citations

• Abstract 727: Association of baseline tumor and peripheral biomarker features with efficacy in metastatic castration-resistant prostate cancer patients treated with xaluritamig

  Cancer Research · 2025-04-21 · 2 citations

• Abstract 1120: Baseline biomarker analyses of patients with chemorefractory <i>KRAS</i> G12C-mutated metastatic colorectal cancer (mCRC) from the phase 3 CodeBreaK 300 study

  Cancer Research · 2025-04-21